97 results on '"Gardner, Jerry"'
Search Results
2. Su1657 IN AN INDIVIDUAL WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID, THE PROBABILITY OF PRURITUS IS HIGHER THAN THAT OF A CLINICAL RESPONSE, BUT PRURITUS IS LESS LIKELY TO BE ATTRIBUTABLE TO THE DRUG.
3. Biobehavioral effects of Tai Chi Qigong in men with prostate cancer: Study design of a three-arm randomized clinical trial
4. Attributable Benefit -- Interpreting Results from Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient
5. Tu1105 Attributable Risk - Interpreting Side Effects in Clinical Trials of Newer Treatments for Constipation at the Level of the Individual Patient
6. 1018 A Questionable Investment for Our Patients: Challenging the Efficacy of New Therapies for Opioid-Induced and Chronic Idiopathic Constipation
7. Missed Opportunity in Zollinger–Ellison Syndrome Research
8. Sa1075 Measures of Effect Size Provide Clinically Relevant Information Regarding the Beneficial Effects of Telaprevir in Hepatitis C
9. Su1070 Development of a Mobile Phone Application to Diagnose GERD
10. Measures of Effect Size Can Avoid Dependence of Odds Ratio and Relative Risk on the Control Response
11. Measures of Effect Size Provide Clinically Relevant Information Regarding the Beneficial Effects PN 400 on Naproxen-Induced Endoscopic Gastric Ulcers
12. T1104 A Bayesian Method Using Esophageal Acid Exposure to Diagnose GERD
13. M1856 Continuous Distal Esophageal Acidification Reduces Postprandial Gastric Acidity in Healthy Human Subjects
14. S1932 A Bayesian Method for Analyzing Relationships Between Esophageal Reflux Episodes and Symptoms
15. How do I interpret a positive diagnostic test?
16. Heartburn severity can predict the presence of pathologic esophageal reflux in patients with GERD
17. Integrated gastric acidity can predict the prevention of naproxen-induced gastroduodenal pathology in normal subjects
18. Measurement of meal-stimulated gastric acid secretion and exophageal pH in ambulatory subjects who ingest typical meals
19. Role of gastric acid in esophageal acid reflux
20. Identification of two distinct pathophysiologic forms of GERD
21. Relationship between esophageal acid exposure and heartburn severity in meal-lnduced heartburn
22. Identification of a novel, beneficial action of proton pump inhibitors in GERD
23. In GERD patients taking a morning dose of omeprazole, bedtime low-dose ranitidine is equivalent to bedtime omeprazole for inhibition of nocturnal gastric acidity
24. Endoscopy-negative GERD is a gastric ‘hypersecretory’ disorder
25. How do provocative meals cause heartburn? Integrated gastric acidity as the determinant of esophageal acid exposure
26. Meal-induced heartburn: Quantification of esophageal acid exposure and its relationship to gastric acidity
27. Determination of onset, duration of action and maximal effect of rabeprazole on gastric and esophageal acidity in GERD
28. Maximal or near-maximal inhibition of esophageal acidity by the 1st dose of rabeprazole in GERD
29. Cellular distribution of isoforms of protein kinase C (PKC) in pancreatic acini
30. Effects of cholecystokinin (CCK) and other secretagogues on isoforms of protein kinase C (PKC) in pancreatic acini
31. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini
32. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini
33. Effect of inhibition of microsomal Ca2+-ATPase on cytoplasmic calcium and enzyme secretion in pancreatic acini
34. Response
35. A newly recognized action of cholecystokinin on pancreatic acini-release of lactate dehydrogenase
36. Gastrointestinal peptides and cancer
37. Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes
38. Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome
39. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome
40. Multiple hormone elevations in Zollinger-Ellison syndrome
41. Detection of duodenal gastrinomas by operative endoscopic transillumination
42. Intravenous omeprazole in patients with Zollinger-Ellison syndrome undergoing surgery
43. Zollinger-Ellison Syndrome
44. Omeprazole: Effective, Convenient Therapy for Zollinger—Ellison Syndrome
45. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors
46. Cholecystokinin-induced residual stimulation of enzyme secretion from mouse pancreatic acini
47. Mechanism by which dibutyryl cyclic guanosine monophosphate antagonizes the action of cholecystokinin
48. The importance of the amino acid in position 32 of cholecystokinin in determining its interaction with cholecystokinin receptors on pancreatic acini
49. Potential mechanisms of interaction among secretagogues
50. Effects of Ouabain on Catecholamine-stimulated Sodium Transport in Turkey Erythrocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.